D.E. Shaw & Co Portfolio holdings
D. E. Shaw & Co., L.P., founded in 1988 by David E. Shaw, a former Columbia University computer science professor, is a New York City-based global investment management firm renowned for pioneering quantitative investing, managing over $70 billion in assets as of late 2024. Starting with $28 million from Paloma Partners and private investors, the firm employs sophisticated mathematical models and proprietary algorithms—initially developed by a team of scientists and programmers—to exploit market anomalies across public and private markets, including equities, fixed income, and alternatives. Headquartered above a Greenwich Village bookstore in its early days, it now boasts over 2,500 employees across offices in North America, Europe, and Asia, led by a seven-member Executive Committee since Shaw stepped back in 2001 to focus on D. E. Shaw Research. Despite setbacks like the 1998 Russia debt crisis and the 2008 financial downturn, the firm has maintained a reputation for analytical rigor, risk management, and innovation, balancing its computational roots with discretionary strategies.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
GE Aerospace
GE
|
+$570M |
| 2 |
Meta Platforms (Facebook)
META
|
+$469M |
| 3 |
TWX
Time Warner Inc
TWX
|
+$342M |
| 4 |
Merck
MRK
|
+$322M |
| 5 |
MON
Monsanto Co
MON
|
+$249M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Apple
AAPL
|
+$434M |
| 2 |
Netflix
NFLX
|
+$301M |
| 3 |
Alibaba
BABA
|
+$245M |
| 4 |
Verizon
VZ
|
+$235M |
| 5 |
Tesla
TSLA
|
+$230M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 13.27% |
| 2 | Healthcare | 11.28% |
| 3 | Consumer Discretionary | 8.99% |
| 4 | Communication Services | 8.03% |
| 5 | Industrials | 7.4% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
2726
Waterstone Financial
WSBF
$362M
| $709K | ﹤0.01% |
41,568
+8,536
| +26% | +$160K |
|
|
TYPE
2727
DELISTED
Monotype Imaging Holdings Inc.
TYPE
| $705K | ﹤0.01% |
29,259
-108,395
| -79% | -$2.54M |
|
2728
CALL
Cheesecake Factory
CAKE
$4.21B
| $703K | ﹤0.01% |
+14,600
| New | +$663K |
|
|
COBZ
2729
DELISTED
CoBiz Financial,Inc
COBZ
| $702K | ﹤0.01% |
35,124
-2,343
| -6% | -$47.5K |
|
2730
CALL
Tucows
TCX
$97.1M
| $701K | ﹤0.01% |
+10,000
| New | +$607K |
|
|
IMMU
2731
DELISTED
Immunomedics Inc
IMMU
| $701K | ﹤0.01% |
43,391
+22,600
| +109% | +$267K |
|
2732
Kforce
KFRC
$983M
| $700K | ﹤0.01% |
27,710
-21,656
| -44% | -$509K |
|
|
QEP
2733
CALL
DELISTED
QEP RESOURCES, INC.
QEP
| $700K | ﹤0.01% |
73,100
-27,900
| -28% | -$253K |
|
2734
Karyopharm Therapeutics
KPTI
$168M
| $699K | ﹤0.01% |
4,851
+814
| +20% | +$131K |
|
2735
CALL
Aon
AON
$77.3B
| $697K | ﹤0.01% |
5,200
+2,200
| +73% | +$313K |
|
2736
IAMGOLD
IAG
$8.47B
| $697K | ﹤0.01% |
119,541
+47,602
| +66% | +$272K |
|
2737
First Financial Bancorp
FFBC
$3.55B
| $691K | ﹤0.01% |
26,207
+13,406
| +105% | +$363K |
|
|
BOLD
2738
DELISTED
Audentes Therapeutics, Inc
BOLD
| $691K | ﹤0.01% |
22,116
-43,236
| -66% | -$1.19M |
|
|
BT
2739
DELISTED
BT Group plc (ADR)
BT
| $691K | ﹤0.01% |
37,928
-189,610
| -83% | -$3.35M |
|
|
TFCFA
2740
PUT
DELISTED
Twenty-First Century Fox, Inc. Class A
TFCFA
| $691K | ﹤0.01% |
20,000
| – | – |
|
|
GGP
2741
DELISTED
GGP Inc.
GGP
| $690K | ﹤0.01% |
+29,501
| New | +$657K |
|
2742
Mercury Insurance
MCY
$5.94B
| $689K | ﹤0.01% |
+12,889
| New | +$709K |
|
2743
W&T Offshore
WTI
$545M
| $689K | ﹤0.01% |
208,243
-649,432
| -76% | -$2.02M |
|
|
ESPR
2744
DELISTED
Esperion Therapeutics
ESPR
| $688K | ﹤0.01% |
+10,456
| New | +$563K |
|
2745
Live Nation Entertainment
LYV
$41.2B
| $688K | ﹤0.01% |
16,153
-180,563
| -92% | -$7.86M |
|
2746
Camden Property Trust
CPT
$11.3B
| $687K | ﹤0.01% |
+7,461
| New | +$690K |
|
2747
PUT
Interactive Brokers
IBKR
$40.9B
| $687K | ﹤0.01% |
46,400
+26,800
| +137% | +$365K |
|
|
STI
2748
PUT
DELISTED
SunTrust Banks, Inc.
STI
| $685K | ﹤0.01% |
10,600
| – | – |
|
2749
PUT
Ecolab
ECL
$75.6B
| $684K | ﹤0.01% |
5,100
| – | – |
|
2750
Enpro
NPO
$7.05B
| $684K | ﹤0.01% |
7,317
-200
| -3% | -$16.9K |
|
Similar funds
D.E. Shaw & Co's Q4 2017 Portfolio in Review
As of Q4 2017, D.E. Shaw & Co held 3,940 positions worth $72.6B, up 12% from $65.1B the previous quarter. Its ten largest holdings account for 9.5% of the portfolio.
D.E. Shaw & Co deployed $3.73B of net new capital in Q4 2017, opening 507 new positions and adding to 1,441 existing holdings. Its largest new stake was iPath S&P 500 VIX Short-Term Futures ETN due 1/30/2019: 3,178,870 shares worth $88.8M.
By sector, the portfolio is most concentrated in Technology at 13% of assets, down from 14% a quarter earlier, followed by Healthcare and Consumer Discretionary.
On the sell side, the largest reduction was Apple, an estimated $434M trimmed.
- D.E. Shaw & Co's largest Q4 2017 buy was iPath S&P 500 VIX Short-Term Futures ETN due 1/30/2019: 3,178,870 shares worth $88.8M.
- D.E. Shaw & Co added most to GE Aerospace in Q4 2017, an estimated $570M increase.
- D.E. Shaw & Co's biggest Q4 2017 reduction was Apple, cutting an estimated $434M.
- D.E. Shaw & Co fully exited Tesla in Q4 2017, selling an estimated $230M.
- D.E. Shaw & Co's ten largest holdings make up 9.5% of its $72.6B portfolio in Q4 2017.
- D.E. Shaw & Co opened 507 new positions and closed 394 in Q4 2017.
- D.E. Shaw & Co's portfolio value rose 12% quarter-over-quarter to $72.6B.
Based on D.E. Shaw & Co's 13F filing for Q4 2017, filed 14 Feb 2018.